Wockhardt Hospital & Wellthy Therapeutics Launches a new Diabetes Clinic at SOBO

Mumbai Central’s Wockhardt Hospital in association with Wellthy Therapeutics, one of South Asia’s leading Digital Therapeutic companies launches a Diabetes Clinic at SOBO whose patients will get access to their digital therapeutic suite for Diabetes (WellD). The newly launched Diabetes clinic will be dedicated to provide accessible medical treatment for patients who seek help for various problems related to the disease.

The rise of technology introduced digital therapeutics and it can be used as stand-alone treatments or as part of a broader treatment program that incorporates both digital and non-digital (conventional) therapies. Commenting on the new clinic, Dr. Parag Rindani, Center Head, Wockhardt Hospital, SOBO, says, “Apart from having access to endocrinologists, diabetes foot surgeons, neurologists, internal medicine experts and other specialties, our patients also stand to benefit from continuous and real-time care provided by Wellthy Therapeutics' digital therapeutic suite, as we enable out-of-clinic extensions to our world-class in-clinic care to help our patients improve their health outcomes”.

With an estimated 8.7 percent diabetic population in the age group of 20 and 70 years, diabetes is a growing challenge in India. Remarkably, India currently represents 49 percent of the world’s diabetes burden, with an estimated 72 million cases in 2017 and astonishingly it is expected to almost double to 134 million by 2025.

Dr. Behram Pardiwala, Internal Medicine Expert, Wockhardt Hospital, SOBO, says, “Lifestyle modification is the most important component of diabetes care. Patients who follow healthy diets and exercise regularly are better positioned to prevent other complications that result from mismanagement of diabetes”.

Founded in 2015, Wellthy is a digital therapeutics company focused on improving patient health through the intersection of technology, and clinical outcomes. Its first digital therapeutic for Type II diabetes has been endorsed by Asia’s largest diabetes association (RSSDI). It recognizes gaps in chronic disease management are exacerbated due to the current paradigm of episodic care which is unable to provide continuous care and coaching to patients with chronic conditions. Mumbai based company is powered by artificial intelligence and specially plays the role of an on-demand nutritionist, educator, fitness coach and counselor enabling patient to develop the skills to reverse the chronic conditions.

Read more news:

What Your Company Should Know Before Migrating to the Cloud

India renews call for WTO reform